Literature DB >> 25793022

Treatment strategies for patients with an INTERMACS I profile.

Walid K Abu Saleh1, Odeaa Al Jabbari1, Ashrith Guha1, Matthias Loebe1, Brian A Bruckner1.   

Abstract

Treatment of patients with INTERMACS class I heart failure can be very challenging, and temporary long-term device support may be needed. In this article, we review the currently available temporary support devices in order to support these severely ill patients with decompensated heart failure. Strategies of using a temporary assist as a bridge to long-term device support are also discussed.

Entities:  

Keywords:  INTERMACS system; cardiac risk factors; heart assist device; heart failure; right heart dysfunction

Mesh:

Year:  2015        PMID: 25793022      PMCID: PMC4362064          DOI: 10.14797/mdcj-11-1-4

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  23 in total

Review 1.  Percutaneous mechanical assistance for the failing heart.

Authors:  Cristiano Freitas de Souza; Flavio de Souza Brito; Valter Correia De Lima; Antonio Carlos De Camargo Carvalho
Journal:  J Interv Cardiol       Date:  2010-03-12       Impact factor: 2.279

2.  First use of the TandemHeart percutaneous left ventricular assist device as a short-term bridge to cardiac transplantation.

Authors:  Saverio La Francesca; Nanthini Palanichamy; Biswajit Kar; Igor D Gregoric
Journal:  Tex Heart Inst J       Date:  2006

3.  Percutaneous endocardial and epicardial ablation of hypotensive ventricular tachycardia with percutaneous left ventricular assist in the electrophysiology laboratory.

Authors:  Paul A Friedman; Thomas M Munger; Norman Torres; Charanjit Rihal
Journal:  J Cardiovasc Electrophysiol       Date:  2007-01

4.  On the fledgling field of mechanical circulatory support.

Authors:  Lynne Warner Stevenson; Gregory Couper
Journal:  J Am Coll Cardiol       Date:  2007-08-06       Impact factor: 24.094

5.  Initial experience with CentriMag extracorporal membrane oxygenation for support of critically ill patients with refractory cardiogenic shock.

Authors:  Tariq A Aziz; Gurpal Singh; Eric Popjes; Edward Stephenson; Suzanne Mulvey; Walter Pae; Aly El-Banayosy
Journal:  J Heart Lung Transplant       Date:  2009-10-17       Impact factor: 10.247

Review 6.  Assist devices for circulatory support in therapy-refractory acute heart failure.

Authors:  Michael M Koerner; Jama Jahanyar
Journal:  Curr Opin Cardiol       Date:  2008-07       Impact factor: 2.161

7.  Percutaneous right ventricular assist device as support for cardiogenic shock due to right ventricular infarction.

Authors:  Jordan M Prutkin; Justin A Strote; Karen K Stout
Journal:  J Invasive Cardiol       Date:  2008-07       Impact factor: 2.022

8.  Usefulness of percutaneous left ventricular assist device as a bridge to recovery from myocarditis.

Authors:  Divay Chandra; Biswajit Kar; Gary Idelchik; Leo Simpson; Pranav Loyalka; Igor D Gregoric; Reynolds M Delgado; O H Frazier
Journal:  Am J Cardiol       Date:  2007-05-02       Impact factor: 2.778

Review 9.  Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock.

Authors:  Holger Thiele; Richard W Smalling; Gerhard C Schuler
Journal:  Eur Heart J       Date:  2007-06-22       Impact factor: 29.983

10.  Clinical experience with the TandemHeart percutaneous ventricular assist device as a bridge to cardiac transplantation.

Authors:  Brian A Bruckner; Leon P Jacob; Igor D Gregoric; Pranav Loyalka; Biswajit Kar; William E Cohn; Saverio La Francesca; Branislav Radovancevic; O H Frazier
Journal:  Tex Heart Inst J       Date:  2008
View more
  1 in total

1.  Left ventricular assist device (LVAD) program in Chile: first successful experience in South America.

Authors:  Oneglio Pedemonte; Andres Vera; Lorenzo Merello; Manuel Novajas; Fernando Aranda; Julio Ibarra; Jose A Muñoz; Javier Alburquerque; Paulina Espinoza; Felipe Cárdenas; Ernesto Aránguiz-Santander
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.